Kestra Advisory Services’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Kestra Advisory Services's NVAX Position: Q3 2026 in Review
Kestra Advisory Services sold out of Novavax (NVAX) in Q3 2026, closing a stake of 28,636 shares — an estimated $270K sold.
Kestra Advisory Services first reported a position in NVAX in Q4 2020 and held it in 7 quarters. The position peaked at $2.67M in Q3 2021. 262 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Kestra Advisory Services reported no remaining Novavax position as of Q3 2026 after selling out during the quarter.
- Kestra Advisory Services sold 28,636 Novavax shares in Q3 2026, an estimated $270K.
- Kestra Advisory Services first reported a position in Novavax in Q4 2020 and held it in 7 quarters.
- Kestra Advisory Services's Novavax position peaked at $2.67M in Q3 2021.
- 262 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.